查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599268

兽医治疗市场：副产品、动物、给药途径和最终用户 - 全球预测 2025-2030

Veterinary Therapeutics Market by Product (Drug Type, Medicated Feed Additive, Vaccines Type), Animal (Companion Animal, Livestock Animal), Route of Administration, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年兽医治疗市场价值为380.5亿美元，预计到2024年将达到407.7亿美元，复合年增长率为7.23%，到2030年将达到620.4亿美元。

兽医治疗市场包括多种专为兽医设计的产品，包括药物、疫苗和诊断工具。由于全球宠物拥有量的增加和对畜产品的需求不断增长，该市场正在应对通用感染疾病日益流行和对先进动物保健解决方案的需求。兽医疗法被广泛的最终用户用来预防、控制和治疗疾病，包括宠物饲主、兽医医院和畜牧养殖者。影响市场的主要成长要素包括药物开发的技术发展、动物保健意识的提高以及政府措施的增加。最近的潜在商机在于宠物人性化的成长趋势、生物製药的进步以及向兽医需求未满足的新兴市场的扩张。此外，数位解决方案和远端医疗在简化兽医护理方面具有巨大潜力。然而，市场面临严格的监管政策、高昂的开发成本以及仿冒品的出现等挑战，这可能会阻碍成长。此外，新兴市场缺乏足够的兽医基础设施，限制了市场扩张。创新成熟的领域包括精准医学、基因组学以及人工智慧在诊断中的应用，这可以提高治疗通讯协定的准确性和有效性。另一个有前景的领域是开发永续且环保的治疗产品，满足对环保解决方案不断增长的需求。该市场的特点是竞争格局，主要製药公司投资于研究和合作伙伴关係以扩大其产品范围。为了利用新的商机，相关人员应专注于产品系列多样化、投资于前沿研究，并根据不断变化的消费者期望和监管环境调整策略。总体而言，由于持续的技术创新以及动物用药品在全球健康动态中的重要性的日益认识，兽药市场有望显着增长。

主要市场统计
基准年[2023] 380.5亿美元
预测年份 [2024] 407.7亿美元
预测年份 [2030] 620.4亿美元
复合年增长率（%） 7.23%

市场动态：快速发展的兽医治疗市场的关键市场洞察

供需的动态交互作用正在改变兽医治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 饲养的伴同性动物和牲畜数量增加
    • 改善经济国家的兽医医疗设施
    • 动物慢性病和意外伤害发生率增加
  • 市场限制因素
    • 兽药高成本
  • 市场机会
    • 各国新产品核可量增加
    • 活性化新治疗药物开发的研究开发活动
  • 市场挑战
    • 品管问题

波特的五力策略工具驾驭兽医治疗市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解兽医治疗市场的外部影响

外部宏观环境因素在塑造兽医治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解兽药市场竞争状况

对兽医治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵兽医治疗市场供应商的绩效评估

FPNV定位矩阵是评估兽医治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划兽医治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对兽医治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 饲养宠物和牲畜的数量增加
      • 改善经济中的兽医护理设施
      • 动物慢性病和意外伤害发生率增加
    • 抑制因素
      • 兽药成本高
    • 机会
      • 经济中新产品核可增加
      • 加强研发活动以开发新治疗方法
    • 任务
      • 品管问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章兽医治疗市场：副产品

  • 药物类型
    • 发炎（药
    • 反脏话
    • 寄生剂
  • 医药添加剂和饲料添加剂
    • 胺基酸
    • 抗生素
    • 网路药房
    • 零售药房
  • 疫苗类型
    • 减毒疫苗
    • 灭活疫苗
    • 重组疫苗

第七章兽医治疗市场：依动物分类

  • 宠物
  • 家畜

第八章兽药市场：依给药途径

  • 口服
  • 胃肠外的
  • 话题

第九章兽医治疗市场：依最终使用者分类

  • 药局/药局
  • 兽医诊所
  • 动物医院

第10章：美洲兽药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太兽药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的兽医治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma Unlimited
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories Inc.
  • ImmuCell Corporation
  • Indian Immunologicals Ltd.
  • Merck & Co. Inc.
  • Neogen Corporation
  • Novartis International AG
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Vetoquinol Group
  • Zoetis, Inc.
Product Code: MRR-034B500303A2

The Veterinary Therapeutics Market was valued at USD 38.05 billion in 2023, expected to reach USD 40.77 billion in 2024, and is projected to grow at a CAGR of 7.23%, to USD 62.04 billion by 2030.

The scope of the veterinary therapeutics market encompasses a wide range of products including pharmaceuticals, vaccines, and diagnostic tools designed for animal health care. Necessitated by the rising global pet ownership and the growing demand for livestock products, this market responds to the increasing prevalence of zoonotic diseases and the need for advanced animal healthcare solutions. Veterinary therapeutics are applied in the prevention, control, and treatment of diseases across a broad spectrum of end-users such as pet owners, veterinary hospitals, and livestock farmers. Key growth factors influencing the market include technological advances in drug development, rising animal healthcare awareness, and increased government initiatives. Recent potential opportunities lie in the growing trend of humanization of pets, the advancement of biopharmaceuticals, and the expansion into emerging markets with underserved veterinary needs. Moreover, digital solutions and telemedicine offer significant potential to streamline veterinary care. However, the market faces challenges such as stringent regulatory policies, high development costs, and the emergence of counterfeit products, which can stifle growth. Additionally, the lack of adequate veterinary infrastructure in developing regions limits market proliferation. Areas ripe for innovation include precision medicine, genomics, and the use of AI in diagnostics, which can enhance the accuracy and efficacy of treatment protocols. Another promising area is the development of sustainable and environmentally friendly therapeutic products, catering to the increasing demand for eco-conscious solutions. The market is characterized by a competitive landscape with major pharmaceutical companies investing in research and partnerships to expand their product offerings. To capitalize on emerging opportunities, stakeholders should focus on diversifying product portfolios, investing in cutting-edge research, and aligning strategies with evolving consumer expectations and regulatory landscapes. Overall, the veterinary therapeutics market is poised for substantial growth driven by continuous innovation and the expanding recognition of the importance of animal health in global health dynamics.

KEY MARKET STATISTICS
Base Year [2023] USD 38.05 billion
Estimated Year [2024] USD 40.77 billion
Forecast Year [2030] USD 62.04 billion
CAGR (%) 7.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Therapeutics Market

The Veterinary Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Improving veterinary care facilities in economies
    • Rising incidence of chronic diseases and accidental injuries in animals
  • Market Restraints
    • High cost of veterinary therapeutics
  • Market Opportunities
    • Growing new product approvals in economies
    • Increasing R&D activities to develop new therapeutics
  • Market Challenges
    • Issues with quality management

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Therapeutics Market

A detailed market share analysis in the Veterinary Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Therapeutics Market

A strategic analysis of the Veterinary Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol Group, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Drug Type, Medicated Feed Additive, and Vaccines Type. The Drug Type is further studied across Anti-Inflammatory, Anti-Invectives, and Parasiticides. The Medicated Feed Additive is further studied across Amino Acids, Antibiotics, Online Pharmacy, and Retail Pharmacy. The Vaccines Type is further studied across Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines.
  • Based on Animal, market is studied across Companion Animal and Livestock Animal.
  • Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
  • Based on End User, market is studied across Pharmacies & Drug Store, Veterinary Clinic, and Veterinary Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing new product approvals in economies
      • 5.1.3.2. Increasing R&D activities to develop new therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with quality management
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Therapeutics Market, by Product

  • 6.1. Introduction
  • 6.2. Drug Type
    • 6.2.1. Anti-Inflammatory
    • 6.2.2. Anti-Invectives
    • 6.2.3. Parasiticides
  • 6.3. Medicated Feed Additive
    • 6.3.1. Amino Acids
    • 6.3.2. Antibiotics
    • 6.3.3. Online Pharmacy
    • 6.3.4. Retail Pharmacy
  • 6.4. Vaccines Type
    • 6.4.1. Attenuated Vaccines
    • 6.4.2. Inactivated Vaccines
    • 6.4.3. Recombinant Vaccines

7. Veterinary Therapeutics Market, by Animal

  • 7.1. Introduction
  • 7.2. Companion Animal
  • 7.3. Livestock Animal

8. Veterinary Therapeutics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
  • 8.4. Topical

9. Veterinary Therapeutics Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmacies & Drug Store
  • 9.3. Veterinary Clinic
  • 9.4. Veterinary Hospital

10. Americas Veterinary Therapeutics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Therapeutics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Therapeutics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Biovac Ltd.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Ceva Sante Animale
  • 5. Chanelle Pharma Unlimited
  • 6. Dechra Pharmaceuticals PLC
  • 7. Elanco Animal Health Incorporated
  • 8. Eli Lilly and Company
  • 9. Heska Corporation
  • 10. Hester Biosciences Limited
  • 11. IDEXX Laboratories Inc.
  • 12. ImmuCell Corporation
  • 13. Indian Immunologicals Ltd.
  • 14. Merck & Co. Inc.
  • 15. Neogen Corporation
  • 16. Novartis International AG
  • 17. Nutreco N.V.
  • 18. Phibro Animal Health Corporation
  • 19. Vetoquinol Group
  • 20. Zoetis, Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 327. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023